抗腺苷酸激酶5抗体相关边缘性脑炎的临床特征
该回顾性研究在50例未明确抗体的边缘性脑炎患者中鉴定出10例抗腺苷酸激酶5(AK5)抗体阳性患者,中位年龄64岁,表现为亚急性顺行性遗忘,多无癫痫发作,脑MRI均见双侧海马高信号,免疫治疗反应多不佳,部分进展为严重认知下降。
要点
- 对亚急性顺行性遗忘的老年患者应系统检测AK5抗体。
- AK5抗体相关边缘性脑炎常无肿瘤,脑MRI双侧海马高信号。
- 免疫治疗多反应不佳,可遗留严重遗忘或认知下降。
核心结论
- AK5抗体相关边缘性脑炎应作为老年亚急性顺行性遗忘的鉴别诊断,早期识别有助于防止不可逆边缘系统损伤。
研究设计与样本
- 回顾性研究,在50例未明确抗体的边缘性脑炎患者中,通过免疫组化、蛋白印迹、免疫沉淀、质谱和细胞学方法鉴定抗体靶点。
主要发现
- 10例患者血清和脑脊液检出AK5抗体,中位年龄64岁(范围57-80),表现为亚急性顺行性遗忘,无癫痫发作,部分有前驱乏力或情绪障碍。
- 部分患者伴面容失认、阵发性焦虑或行为异常,所有10例脑MRI均显示双侧海马高信号。
- 脑脊液常见轻度细胞增多、IgG指数升高和寡克隆带,tau蛋白升高而Aβ42和磷酸化tau正常,提示神经元死亡过程。
- 除1例外,免疫治疗反应不佳,持续严重顺行性遗忘,2例进展为严重认知下降,随访脑MRI见海马萎缩。
- 体外海马神经元实验未发现AK5抗体直接致病作用的线索。
临床怎么用
- 对老年亚急性顺行性遗忘患者应尽早检测AK5抗体以明确诊断。
- 即使免疫治疗反应不佳,识别该病仍有助于探索新治疗策略以预防不可逆边缘系统损伤。
局限性
- 回顾性研究,样本量小(10例),未明确AK5抗体的直接致病机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To report 10 patients with limbic encephalitis (LE) and adenylate kinase 5 autoantibodies (AK5-Abs). METHODS: We conducted a retrospective study in a cohort of 50 patients with LE with uncharacterized autoantibodies and identified a specific target using immunohistochemistry, Western blotting, immunoprecipitation, mass spectrometry, and cell-based assay. RESULTS: AK5 (a known autoantigen of LE) was identified as the target of antibodies in the CSFs and sera of 10 patients with LE (median age 64 years; range 57-80), which was characterized by subacute anterograde amnesia without seizure and sometimes preceded by a prodromal phase of asthenia or mood disturbances. Anterograde amnesia can be isolated, but some patients also complained of prosopagnosia, paroxysmal anxiety, or abnormal behavior. No associated cancer was observed. All 10 patients had bilateral hippocampal hypersignal on a brain MRI. CSF analysis generally showed a mild pleiocytosis with elevated immunoglobulin G index and oligoclonal bands, as well as high levels of tau protein with normal concentration of Aβ42 and phospho-tau, suggesting a process of neuronal death. Except for one patient, clinical response to immunotherapy was unfavorable, with persistence of severe anterograde amnesia. Two patients evolved to severe cognitive decline. Hippocampal atrophy was observed on control brain MRI. Using in vitro tests on hippocampal neurons, we did not identify clues suggesting a direct pathogenic role of AK5-Abs. CONCLUSIONS: AK5-Abs should be systematically considered in aged patients with subacute anterograde amnesia. Recognition of this disorder is important to develop new treatment strategies to prevent irreversible limbic damage.
引用
- Do LD, Chanson E, Desestret V, et al. Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies. Neurology. 2017. PMID: 28062719. doi:10.1212/WNL.0000000000003586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。